Dr. Daniel Katz, MD
Claim this profileIcahn School of Medicine at Mount SInai
Studies Cesarean Section
Studies Spinal Anesthesia
6 reported clinical trials
9 drugs studied
Affiliated Hospitals
Clinical Trials Daniel Katz, MD is currently running
Ephedrine
for Childbirth
Labor analgesia is an important component of the care of laboring patients. A known side effect of combined spinal and epidural anesthesia (a type of labor analgesia) is an increased incidence of category II fetal heart rate tracing (defined below) and low blood pressure. The study team aims to study if a prophylactic dose of ephedrine will decrease the occurrence of this type of tracing after combined spinal epidural (CSE) anesthesia placement. Ephedrine is not currently routinely used as prevention for category II tracings or low blood pressure. The use of Ephedrine in this study is investigational (this is the first time that the drug has been studied for its effect on these conditions). Fetal heart rate (FHR) tracings are classified into three categories. In clinical practice, FHR tracing categories are used as a guide to obstetric management and suggest the following approach: * Category I tracing is "reactive" and reassuring → may continue labor * Category II tracing is neither category I nor category III. For obvious reasons, category II is the broadest and largest category, consisting of various FHR tracing patterns that do not fit into either category I or category III. * Category III tracing is non-reassuring → expedited vaginal or cesarean delivery recommended. A Category II tracing is not diagnostic. Most pregnancies have at least one Category II tracing. There is not always an identifiable reason for a Category II tracing. Ephedrine is a medication that causes an increase in heart rate and blood pressure while also causing some degree of relaxation of the uterus therefore improving uterine blood flow. It has been used in the obstetric population for over 50 years without issues. The dose that the research team will administer, 7.5 mg, is below the dose the research team will often administer to treat hypotension (low blood pressure).
Recruiting2 awards Phase 4
Auricular Neuromodulation
for Sinus Surgery
In this blinded prospective randomized control trial the researchers will investigate the impact of cutaneous vagal nerve stimulation on surgical conditions in patients undergoing functional and ascorbic sinus surgery (FESS). The device is an externally placed vagal nerve stimulator. The device will be applied to participants after consent and induction of anesthesia. The study team will open the randomization envelope and if the participant is assigned to stimulation the device will be turned on. In the case that the participant is assigned to the control arm, the device will be set to sham. The device will remain on for 30 minutes and removed before entering the OR. Device will be reinserted in the recovery room for another 30 minutes.
Recruiting0 awards N/A1 criteria
More about Daniel Katz, MD
Clinical Trial Related1 year of experience running clinical trials · Led 6 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Daniel Katz, MD has experience with
- Dexmedetomidine
- Epinephrine
- Intraoperative Cellular Salvage
- Auricular Neuromodulation
- Bupivacaine
- Bupivacaine Liposome
Breakdown of trials Daniel Katz, MD has run
Cesarean Section
Spinal Anesthesia
Postpartum Anemia
Functional Endoscopic Sinus Surgery
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Daniel Katz, MD specialize in?
Daniel Katz, MD focuses on Cesarean Section and Spinal Anesthesia. In particular, much of their work with Cesarean Section has involved treating patients, or patients who are undergoing treatment.
Is Daniel Katz, MD currently recruiting for clinical trials?
Yes, Daniel Katz, MD is currently recruiting for 6 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Daniel Katz, MD has studied deeply?
Yes, Daniel Katz, MD has studied treatments such as Dexmedetomidine, Epinephrine, Intraoperative Cellular Salvage.
What is the best way to schedule an appointment with Daniel Katz, MD?
Apply for one of the trials that Daniel Katz, MD is conducting.
What is the office address of Daniel Katz, MD?
The office of Daniel Katz, MD is located at: Icahn School of Medicine at Mount SInai, New York, New York 10029 United States. This is the address for their practice at the Icahn School of Medicine at Mount SInai.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.